Pazopanib - GlaxoSmithKline/Novartis
At a glance
- Drug Originator GlaxoSmithKline
- Drug Licenced by BeiGene
- Drug Class Amines; Antineoplastics; Indazoles; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action Angiogenesis inhibitors; Platelet-derived growth factor receptor antagonists; Proto oncogene protein b raf inhibitors; Proto oncogene protein c-kit inhibitors; Vascular endothelial growth factor receptor 3 antagonists; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-2 antagonists
- USA Patent Applicants NOVARTIS
- USA Patents 6
- NDAs 1
- International Patents 40
- Patent Applications 704
Table of Contents

Disclaimer